新型直接作用抗病毒药物对埃及慢性丙型肝炎患者血液学和免疫学的影响

Afro-Egyptian Journal of Infectious and Endemic Diseases Pub Date : 2022-05-24 DOI:10.21608/aeji.2022.122669.1206

S. Hussein, Howaida A. Nafady, T. Hassan

{"title":"新型直接作用抗病毒药物对埃及慢性丙型肝炎患者血液学和免疫学的影响","authors":"S. Hussein, Howaida A. Nafady, T. Hassan","doi":"10.21608/aeji.2022.122669.1206","DOIUrl":null,"url":null,"abstract":"CD+4, CD3+CD4+, CD3+CD8+, CD3−CD8+ cells)) at 3-months post-therapy. Conclusion: Although combination of Sofosbuvir and Dacltasvir was safe and effective in management of chronic HCV infection but its effect on the immune cells is still unclear. Further studies are in need to confirm such results.","PeriodicalId":261891,"journal":{"name":"Afro-Egyptian Journal of Infectious and Endemic Diseases","volume":"71 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessment of Haematological and Immunological Effect after New Direct ‎Acting Antiviral Drugs in Chronic Hepatitis C Virus Egyptian Patients\",\"authors\":\"S. Hussein, Howaida A. Nafady, T. Hassan\",\"doi\":\"10.21608/aeji.2022.122669.1206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"CD+4, CD3+CD4+, CD3+CD8+, CD3−CD8+ cells)) at 3-months post-therapy. Conclusion: Although combination of Sofosbuvir and Dacltasvir was safe and effective in management of chronic HCV infection but its effect on the immune cells is still unclear. Further studies are in need to confirm such results.\",\"PeriodicalId\":261891,\"journal\":{\"name\":\"Afro-Egyptian Journal of Infectious and Endemic Diseases\",\"volume\":\"71 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Afro-Egyptian Journal of Infectious and Endemic Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/aeji.2022.122669.1206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Afro-Egyptian Journal of Infectious and Endemic Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/aeji.2022.122669.1206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

CD3+ 4, CD3+CD4+， CD3+CD8+， CD3−CD8+细胞))治疗后3个月。结论:索非布韦联合达克他韦治疗慢性HCV感染安全有效，但对免疫细胞的影响尚不清楚。需要进一步的研究来证实这些结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Assessment of Haematological and Immunological Effect after New Direct ‎Acting Antiviral Drugs in Chronic Hepatitis C Virus Egyptian Patients

CD+4, CD3+CD4+, CD3+CD8+, CD3−CD8+ cells)) at 3-months post-therapy. Conclusion: Although combination of Sofosbuvir and Dacltasvir was safe and effective in management of chronic HCV infection but its effect on the immune cells is still unclear. Further studies are in need to confirm such results.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Afro-Egyptian Journal of Infectious and Endemic Diseases

自引率

0.00%

发文量